Sort   by:  
 Page size 
UnknownA secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells.
Not available
S-EPMC2000837 | biostudies-literature
UnknownIn vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors.
Not available
S-EPMC122986 | biostudies-literature
UnknownPseudogene Associated Recurrent Gene Fusion in Prostate Cancer.
Not available
S-EPMC6713813 | biostudies-literature
UnknownMesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis.
Not available
S-EPMC9414743 | biostudies-literature
UnknownInhibition of GATA2 in prostate cancer by a clinically available small molecule.
Not available
S-EPMC8634153 | biostudies-literature
UnknownETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.
Not available
S-EPMC10075989 | biostudies-literature
UnknownMechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
Not available
S-EPMC3113473 | biostudies-literature
UnknownProstate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.
Not available
S-EPMC4407499 | biostudies-literature
UnknownPin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection.
Not available
S-EPMC9610092 | biostudies-literature
TranscriptomicsMechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion Positive Prostate Cancer
To identify commonly altered genes between ERG, PARP1, and DNA-PKcs. Two-condition experiment: Each siRNA, targeting either DNA-PKcs or PARP1, was compared to a control RNA.
ORGANISM(S): Homo sapiens 
2011-05-18 | E-GEOD-27723 | biostudies-arrayexpress
Sort   by:  
 Page size